NCT00853983View on ClinicalTrials.gov

Phase I Study to Assess Absorption, Metabolism & Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

March 31, 2009

Study Completion Date

April 30, 2009

Conditions

Healthy

Interventions

DRUG

[14C] AZD0530

Solution, Oral, once

Trial Locations (1)

Unknown

Research Site, Alderley Park

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY